ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.60
0.00%
US Tech 100
19,419.20
0.09%
S&P 500
5,473.23
0.00%
US Dollar vs CAD
1.37367
0.17%
Bitcoin
64,987.97
-2.25%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Jazz Pharmaceuticals PLC (JAZZ)

  7. Jazz Pharmaceuticals PLC (JAZZ) News

JAZZ

Jazz Pharmaceuticals (JAZZ)

Jazz Pharmaceuticals PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:JAZZ
DateTimeSourceHeadlineSymbolCompany
06/14/20243:12PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:JAZZJazz Pharmaceuticals PLC
06/14/20243:11PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:JAZZJazz Pharmaceuticals PLC
06/11/20247:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
06/07/20243:44PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
06/03/20243:28PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:JAZZJazz Pharmaceuticals PLC
06/01/20247:05AMPR Newswire (US)Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024NASDAQ:JAZZJazz Pharmaceuticals PLC
05/31/20244:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:JAZZJazz Pharmaceuticals PLC
05/30/20246:30AMPR Newswire (US)Jazz Pharmaceuticals Showcases Pioneering Research in Sleep Medicine at SLEEP 2024NASDAQ:JAZZJazz Pharmaceuticals PLC
05/29/20243:15PMPR Newswire (US)Jazz Pharmaceuticals to Participate in Upcoming June Investor ConferencesNASDAQ:JAZZJazz Pharmaceuticals PLC
05/29/20243:15PMPR Newswire (US)Jazz Pharmaceuticals to Participate in Upcoming June Investor ConferencesNASDAQ:JAZZJazz Pharmaceuticals PLC
05/29/20246:45AMPR Newswire (US)Zanidatamab Granted Priority Review for HER2-Positive Metastatic Biliary Tract CancerNASDAQ:JAZZJazz Pharmaceuticals PLC
05/22/20247:00AMPR Newswire (US)Jazz Pharmaceuticals Announces Collaboration with Life Science Cares to Improve the Wellbeing of Under Resourced Communities through Employee VolunteerismNASDAQ:JAZZJazz Pharmaceuticals PLC
05/07/20244:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
05/01/20243:10PMPR Newswire (US)Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care ConferenceNASDAQ:JAZZJazz Pharmaceuticals PLC
05/01/20243:10PMPR Newswire (US)Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care ConferenceNASDAQ:JAZZJazz Pharmaceuticals PLC
05/01/20243:05PMPR Newswire (US)Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial GuidanceNASDAQ:JAZZJazz Pharmaceuticals PLC
04/24/20243:05PMPR Newswire (US)Jazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024NASDAQ:JAZZJazz Pharmaceuticals PLC
04/17/20243:15PMPR Newswire (US)Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024NASDAQ:JAZZJazz Pharmaceuticals PLC
04/10/20246:45AMPR Newswire (US)Jazz Pharmaceuticals to Showcase Expansive Neuroscience Portfolio at American Academy of Neurology Annual MeetingNASDAQ:JAZZJazz Pharmaceuticals PLC
04/02/20246:30AMPR Newswire (US)Jazz Pharmaceuticals Completes Zanidatamab Biologics License Application for Previously Treated HER2-Positive Metastatic Biliary Tract CancerNASDAQ:JAZZJazz Pharmaceuticals PLC
03/12/20243:15PMPR Newswire (US)Jazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on Tuesday, March 19, 2024NASDAQ:JAZZJazz Pharmaceuticals PLC
03/12/20243:15PMPR Newswire (US)Jazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on Tuesday, March 19, 2024NASDAQ:JAZZJazz Pharmaceuticals PLC
03/08/20245:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
03/07/20248:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
03/07/20248:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
03/07/20248:48PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
03/07/20248:47PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
03/07/20245:09PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
03/05/20246:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
03/05/20246:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
 Showing the most relevant articles for your search:NASDAQ:JAZZ

Your Recent History

BOV
PNVL3Q
DIMED ON
LSE
NCYT
Novacyt
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved